Literature DB >> 29057620

The genetic and environmental architecture of substance use development from early adolescence into young adulthood: a longitudinal twin study of comorbidity of alcohol, tobacco and illicit drug use.

Trine Waaktaar1, Kees-Jan Kan2,3, Svenn Torgersen1.   

Abstract

AIMS: To investigate how use of alcohol, illicit drugs and tobacco come from substance-specific pathways and from pathways general to all three substances through adolescent development.
DESIGN: Analysis of population-based survey. Adolescent twins reported alcohol use (AU), tobacco use (TU) and illicit drug use (IDU) in three waves (2006, 2008, 2010). Restructuring data by age allowed for variance decomposition into age- and substance-specific and common genetic and environmental variance components.
SETTING: Norway. PARTICIPANTS: Seven national twin birth cohorts from 1988 to 1994, totalling 1483 pairs (558 monozygotic; 925 dizygotic, same and opposite sex). MEASUREMENTS: Six-point Likert scores of AU, TU and IDU on items from the Monitoring the Future Study.
FINDINGS: Substance use was found to be highly heritable; a2  = 0.73 [95% confidence interval (CI) = 0.61-0.94] for AU, a2  = 0.36 (CI = 0.18-0.52); d2  = 0.49 (95% CI = 0.29-0.62) for IDU and a2  = 0.46 (95% CI = 0.23-0.54); d2  = 0.05 (95% CI = 0.00-0.07) for TU during the whole adolescence period. General substance use (GSU) was also highly heritable at each age and averaged a2  = 0.57 (95% CI = 0.48-0.66). There was a high genetic carry-over from earlier age to later age. Genetic effects on GSU at ages 12-14 years were still detectable 4 years later. New substance (general and specific)-genetic effects also appeared. IDU demonstrated significant non-additive genetic effects (ages 12-14 years). Shared environment had a small impact on AU only. There was almost no non-shared environmental carry-over from age to age, the effect probably due partly to reliability deficiency. Common genetic effects among substance and substance-specific genetic effects were observed at each age-period.
CONCLUSIONS: Among Norwegian adolescents, there appear to be strong genetic effects on both substance-specific and comorbid use of alcohol, illicit drugs and tobacco; individual differences in alcohol use can be explained partially by family background.
© 2017 Society for the Study of Addiction.

Entities:  

Keywords:  Adolescence; alcohol use; comorbidity; heritability; illicit drug use; longitudinal; substance use; tobacco use; twin study

Mesh:

Year:  2017        PMID: 29057620     DOI: 10.1111/add.14076

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  4 in total

1.  Longitudinal associations between youth tobacco and substance use in waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study.

Authors:  Marushka L Silveira; Kevin P Conway; Victoria R Green; Karin A Kasza; James D Sargent; Nicolette Borek; Cassandra A Stanton; Amy Cohn; Nahla Hilmi; K Michael Cummings; Raymond S Niaura; Elizabeth Y Lambert; Mary F Brunette; Izabella Zandberg; Susanne E Tanski; Chad J Reissig; Priscilla Callahan-Lyon; Wendy I Slavit; Andrew J Hyland; Wilson M Compton
Journal:  Drug Alcohol Depend       Date:  2018-07-25       Impact factor: 4.492

2.  Development of individuals' own and perceptions of peers' substance use from early adolescence to adulthood.

Authors:  Jennifer E Lansford; Natalie Goulter; Jennifer Godwin; Max Crowley; Robert J McMahon; John E Bates; Gregory S Pettit; Mark Greenberg; John E Lochman; Kenneth A Dodge
Journal:  Addict Behav       Date:  2021-04-20       Impact factor: 4.591

Review 3.  Genetically selected alcohol-preferring msP rats to study alcohol use disorder: Anything lost in translation?

Authors:  Anna Maria Borruto; Serena Stopponi; Hongwu Li; Friedbert Weiss; Marisa Roberto; Roberto Ciccocioppo
Journal:  Neuropharmacology       Date:  2021-01-18       Impact factor: 5.273

4.  Preadult polytoxicomania-strong environmental underpinnings and first genetic hints.

Authors:  Agnes A Steixner-Kumar; Vinicius Daguano Gastaldi; Jan Seidel; Albert Rosenberger; Martin Begemann; Hannelore Ehrenreich
Journal:  Mol Psychiatry       Date:  2021-04-07       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.